Piedmont Cancer Institute, P.C Site Number : 1226 — Atlanta, Georgia

Piedmont Cancer Institute, P.C Site Number : 1226 is a clinical research site located in Atlanta, Georgia, United States 30290.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Piedmont Cancer Institute, P.C Site Number : 1226 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Cold Agglutinin Disease (CAD), Cold Agglutinin Syndrome (CAS).

Sponsors: RECORDATI GROUP.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Piedmont Cancer Institute, P.C Site Number : 1226?

Piedmont Cancer Institute, P.C Site Number : 1226 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Piedmont Cancer Institute, P.C Site Number : 1226 conducted?

Piedmont Cancer Institute, P.C Site Number : 1226 has 1 clinical trials on record, with 1 currently active. Their work covers Cold Agglutinin Disease (CAD), Cold Agglutinin Syndrome (CAS).

Is Piedmont Cancer Institute, P.C Site Number : 1226 accredited by Crixeo Health?

Piedmont Cancer Institute, P.C Site Number : 1226 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Piedmont Cancer Institute, P.C Site Number : 1226?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.